Get the Stockscreener App
7.18
1.92%
0.135
Kamada Ltd stock is traded at $7.18, with a volume of 21,642.
It is up +1.92% in the last 24 hours and down -6.02% over the past month.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.
See More
Previous Close:
$7.045
Open:
$7.11
24h Volume:
21,642
Relative Volume:
0.34
Market Cap:
$412.31M
Revenue:
$154.57M
Net Income/Loss:
$15.07M
P/E Ratio:
26.59
EPS:
0.27
Net Cash Flow:
$10.92M
1W Performance:
-2.31%
1M Performance:
-6.02%
6M Performance:
-3.75%
1Y Performance:
+29.14%
1-Day Range:
$7.11
$7.28
1-Week Range:
$6.92
$7.3399
52-Week Range:
$5.17
$9.155
Kamada Ltd Stock (KMDA) Company Profile
Compare KMDA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
KMDA
Kamada Ltd
|
7.18 | 412.31M | 154.57M | 15.07M | 10.92M | 0.27 |
|
ZTS
Zoetis Inc
|
156.62 | 67.51B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.52 | 47.88B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.82 | 43.42B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.46 | 20.72B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
312.23 | 14.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Kamada Ltd Stock (KMDA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-21-25 | Initiated | The Benchmark Company | Buy |
| Jul-03-24 | Initiated | Stifel | Buy |
| Feb-02-18 | Initiated | Chardan Capital Markets | Buy |
Kamada Ltd Stock (KMDA) Latest News
Will Kamada Ltd. rebound enough to break evenTrade Exit Report & AI Powered Market Trend Analysis - Newser
How sentiment analysis helps forecast Kamada Ltd.2025 EndofYear Setup & Trade Opportunity Analysis - Newser
Real time pattern detection on Kamada Ltd. stockDip Buying & Technical Confirmation Trade Alerts - Newser
Analyzing Kamada Ltd. with multi timeframe charts2025 EndofYear Setup & Growth Focused Stock Pick Reports - Newser
Using Bollinger Bands to evaluate Kamada Ltd.2025 EndofYear Setup & Growth Focused Stock Pick Reports - Newser
Published on: 2025-08-19 06:25:32 - Newser
Kamada Ltd. stock prediction for this weekPortfolio Return Summary & Precise Buy Zone Tips - Newser
What data driven models say about Kamada Ltd.’s futureEarnings Trend Report & Growth Focused Stock Pick Reports - Newser
Strategies to average down on Kamada Ltd.July 2025 Setups & Safe Capital Growth Stock Tips - Newser
Quantitative breakdown of Kamada Ltd. recent moveJuly 2025 Recap & Capital Protection Trade Alerts - Newser
What does recent volatility data suggest for Kamada Ltd.2025 Technical Overview & Risk Controlled Swing Trade Alerts - Newser
Using RSI to spot recovery in Kamada Ltd.Market Performance Summary & Daily Entry Point Alerts - Newser
Is Kamada Ltd. a play on infrastructure spendingJuly 2025 Short Interest & Free Daily Entry Point Trade Alerts - newsimpact.co.kr
How hedge fund analytics apply to Kamada Ltd. stockPortfolio Value Report & Free Accurate Trade Setup Notifications - Newser
Should you hold or exit Kamada Ltd. nowJuly 2025 Pullbacks & Proven Capital Preservation Tips - Newser
How Kamada Ltd. stock performs during market volatilityWeekly Trend Summary & Risk Managed Trade Strategies - thegnnews.com
HC Wainwright Issues Optimistic Estimate for Kamada Earnings - Defense World
Sentiment analysis tools applied to Kamada Ltd.Market Activity Recap & Accurate Intraday Trading Signals - Newser
How to recover losses in Kamada Ltd. stockJuly 2025 Summary & Free Long-Term Investment Growth Plans - Newser
Kamada Ltd. Reports Strong Financial Results and FDA Approval in August 2025 - MSN
Is Kamada Ltd. still worth holding after the dipRisk Management & Daily Profit Maximizing Tips - Newser
Kamada Ltd. Achieves 11% Revenue Growth, Raises EBITDA Guidance - AInvest
Kamada stock price target maintained at $15 by Benchmark on strong earnings - Investing.com
Kamada Ltd. (NASDAQ:KMDA) Q2 2025 Earnings Call Transcript - Insider Monkey
Kamada: Q2 Earnings Snapshot - Greenwich Time
Momentum Traders Eye Kamada Ltd. for Quick BounceJuly 2025 Earnings & Real-Time Chart Breakout Alerts - beatles.ru
Kamada Ltd (KMDA) Q2 2025 Earnings Call Highlights: Strong Revenue Growth and Increased ... - Yahoo Finance
Kamada Ltd. Reports Strong 2025 Financial Growth - TipRanks
Kamada's Q2 2025: Tax Rate Fluctuations and Clinical Enrollment Contradictions Unveiled - AInvest
Kamada Q2 2025 Earnings Call Transcript - MarketBeat
Kamada Reports Strong Q2 Earnings, Raises Full-Year Guidance, and Secures FDA Approval for Plasma Collection Center - AInvest
Kamada Ltd Outpaces Expectations As FDA Nod Adds Fuel - Finimize
Kamada Ltd Outpaces Expectations With Strong Results And Upbeat Forecast - Finimize
Kamada Ltd reports results for the quarter ended June 30Earnings Summary - TradingView
Kamada's Q2 Earnings and Strategic Growth Catalysts: A Deep Dive into a Biopharma Innovator's Scalable Model - AInvest
Will breakout in Kamada Ltd. lead to full recoveryMarket Volume Report & Weekly High Momentum Picks - Newser
Kamada Reports Strong Second Quarter and First Half 2025 - GlobeNewswire
Kamada Reports Q2 Earnings: EPS Beats Expectations, Revenue Misses - AInvest
Kamada Raises Full-Year Guidance as Plasma Therapy Sales Drive 35% Profit Growth - Stock Titan
Kamada Ltd Stock (KMDA) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.37%
0.37%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):